Alderley Analytical Ltd Email Format
Pharmaceutical ManufacturingEngland, United Kingdom11-50 Employees
Alderley Analytical is an independent contract research organization that provides specialist bioanalytical services to support drug development from discovery through late-stage clinical development. It serves biotech, pharmaceutical and CRO clients and focuses on small molecules, large molecules, peptides, biologics and biomarkers, aiming to reduce laboratory transfers and preserve molecule-specific knowledge by consolidating bioanalysis with a single provider. The company emphasizes a flexible and responsive approach to developing novel bioanalytical methods and delivering timely, high-quality results, with clear communication throughout the process. The laboratory is GLP and GCP accredited, enabling regulatory-compliant validation and delivering results that align with current FDA/EMA guidelines. Based at Alderley Park in North West England, Alderley Analytical operates as a smaller, specialized CRO within the pharmaceutical manufacturing landscape. In October 2024, the company was acquired by Synexa Life Sciences, a Dutch-based firm, reflecting integration into a broader provider of bioanalytical services.